365 related articles for article (PubMed ID: 35777761)
1. Bone morphogenetic protein 4 inhibits pulmonary fibrosis by modulating cellular senescence and mitophagy in lung fibroblasts.
Guan R; Yuan L; Li J; Wang J; Li Z; Cai Z; Guo H; Fang Y; Lin R; Liu W; Wang L; Zheng Q; Xu J; Zhou Y; Qian J; Ding M; Luo J; Li Y; Yang K; Sun D; Yao H; He J; Lu W
Eur Respir J; 2022 Dec; 60(6):. PubMed ID: 35777761
[TBL] [Abstract][Full Text] [Related]
2. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
3. Effects of bone morphogenetic protein 4 on TGF-
Cai Z; Guo H; Qian J; Liu W; Li Y; Yuan L; Zhou Y; Lin R; Xie X; Yang Q; Wu G; Li Q; Zhao L; Liu F; Wang J; Lu W
PeerJ; 2022; 10():e13775. PubMed ID: 35915750
[TBL] [Abstract][Full Text] [Related]
4. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
[TBL] [Abstract][Full Text] [Related]
5. LncRNA GAS5 suppresses TGF-β1-induced transformation of pulmonary pericytes into myofibroblasts by recruiting KDM5B and promoting H3K4me2/3 demethylation of the PDGFRα/β promoter.
Wang Y; Chen D; Xie H; Zhou S; Jia M; He X; Guo F; Lai Y; Tang XX
Mol Med; 2023 Mar; 29(1):32. PubMed ID: 36918759
[TBL] [Abstract][Full Text] [Related]
6. The small heat-shock protein αB-crystallin is essential for the nuclear localization of Smad4: impact on pulmonary fibrosis.
Bellaye PS; Wettstein G; Burgy O; Besnard V; Joannes A; Colas J; Causse S; Marchal-Somme J; Fabre A; Crestani B; Kolb M; Gauldie J; Camus P; Garrido C; Bonniaud P
J Pathol; 2014 Mar; 232(4):458-72. PubMed ID: 24307592
[TBL] [Abstract][Full Text] [Related]
7. Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation.
Liu P; Miao K; Zhang L; Mou Y; Xu Y; Xiong W; Yu J; Wang Y
Respir Res; 2020 Feb; 21(1):58. PubMed ID: 32075634
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
[TBL] [Abstract][Full Text] [Related]
9. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production.
Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ
J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709
[TBL] [Abstract][Full Text] [Related]
10. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.
Enomoto Y; Matsushima S; Shibata K; Aoshima Y; Yagi H; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
Clin Sci (Lond); 2018 Jul; 132(14):1565-1580. PubMed ID: 30006483
[TBL] [Abstract][Full Text] [Related]
11. MARCH8 downregulation modulates profibrotic responses including myofibroblast differentiation.
Guo X; Adeyanju O; Olajuyin AM; Mandlem V; Sunil C; Adewumi J; Huang S; Tucker TA; Idell S; Qian G
Am J Physiol Cell Physiol; 2023 Nov; 325(5):C1190-C1200. PubMed ID: 37661917
[TBL] [Abstract][Full Text] [Related]
12. EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis.
Xiao X; Senavirathna LK; Gou X; Huang C; Liang Y; Liu L
Physiol Rep; 2016 Sep; 4(17):. PubMed ID: 27582065
[TBL] [Abstract][Full Text] [Related]
13. Eliglustat exerts anti-fibrotic effects by activating SREBP2 in TGF-β1-treated myofibroblasts derived from patients with idiopathic pulmonary fibrosis.
Kurumiya E; Iwata M; Kasuya Y; Tatsumi K; Honda T; Murayama T; Nakamura H
Eur J Pharmacol; 2024 Mar; 966():176366. PubMed ID: 38296153
[TBL] [Abstract][Full Text] [Related]
14. Sirtuin 6 inhibits myofibroblast differentiation via inactivating transforming growth factor-β1/Smad2 and nuclear factor-κB signaling pathways in human fetal lung fibroblasts.
Zhang Q; Tu W; Tian K; Han L; Wang Q; Chen P; Zhou X
J Cell Biochem; 2019 Jan; 120(1):93-104. PubMed ID: 30230565
[TBL] [Abstract][Full Text] [Related]
15. miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2.
Fierro-Fernández M; Busnadiego Ó; Sandoval P; Espinosa-Díez C; Blanco-Ruiz E; Rodríguez M; Pian H; Ramos R; López-Cabrera M; García-Bermejo ML; Lamas S
EMBO Rep; 2015 Oct; 16(10):1358-77. PubMed ID: 26315535
[TBL] [Abstract][Full Text] [Related]
16. TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling.
Boutanquoi PM; Burgy O; Beltramo G; Bellaye PS; Dondaine L; Marcion G; Pommerolle L; Vadel A; Spanjaard M; Demidov O; Mailleux A; Crestani B; Kolb M; Garrido C; Goirand F; Bonniaud P
Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32184320
[TBL] [Abstract][Full Text] [Related]
17. N-butyldeoxynojirimycin (miglustat) ameliorates pulmonary fibrosis through inhibition of nuclear translocation of Smad2/3.
Nakamura H; Zhou Y; Sakamoto Y; Yamazaki A; Kurumiya E; Yamazaki R; Hayashi K; Kasuya Y; Watanabe K; Kasahara J; Takabatake M; Tatsumi K; Yoshino I; Honda T; Murayama T
Biomed Pharmacother; 2023 Apr; 160():114405. PubMed ID: 36804125
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor-1 attenuates TGF-β1-induced lung fibrosis.
Shimbori C; Bellaye PS; Xia J; Gauldie J; Ask K; Ramos C; Becerril C; Pardo A; Selman M; Kolb M
J Pathol; 2016 Oct; 240(2):197-210. PubMed ID: 27425145
[TBL] [Abstract][Full Text] [Related]
19. DOCK2 contributes to pulmonary fibrosis by promoting lung fibroblast to myofibroblast transition.
Guo X; Adeyanju O; Sunil C; Mandlem V; Olajuyin A; Huang S; Chen SY; Idell S; Tucker TA; Qian G
Am J Physiol Cell Physiol; 2022 Jul; 323(1):C133-C144. PubMed ID: 35584329
[TBL] [Abstract][Full Text] [Related]
20. Lysine-specific demethylase-1 regulates fibroblast activation in pulmonary fibrosis via TGF-β1/Smad3 pathway.
Pan X; Li J; Tu X; Wu C; Liu H; Luo Y; Dong X; Li X; Pan LL; Sun J
Pharmacol Res; 2020 Feb; 152():104592. PubMed ID: 31830521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
